Prudential Financial’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43K | Buy |
+18,845
| New | +$59.8K | ﹤0.01% | 2334 |
|
|
2025
Q4 | – | Sell |
-15,893
| Closed | -$134K | – | 2287 |
|
|
2025
Q3 | $134K | Buy |
15,893
+40
| +0.3% | +$388 | ﹤0.01% | 2256 |
|
|
2025
Q2 | $188K | Buy |
+15,853
| New | +$146K | ﹤0.01% | 2220 |
|
|
2024
Q4 | – | Sell |
-12,256
| Closed | -$347K | – | 2390 |
|
|
2024
Q3 | $347K | Sell |
12,256
-124
| -1% | -$3.2K | ﹤0.01% | 2359 |
|
|
2024
Q2 | $237K | Buy |
12,380
+911
| +8% | +$23.3K | ﹤0.01% | 2433 |
|
|
2024
Q1 | $376K | Sell |
11,469
-410
| -3% | -$13.1K | ﹤0.01% | 2266 |
|
|
2023
Q4 | $392K | Buy |
11,879
+754
| +7% | +$21.3K | ﹤0.01% | 2233 |
|
|
2023
Q3 | $303K | Sell |
11,125
-4,756
| -30% | -$132K | ﹤0.01% | 2260 |
|
|
2023
Q2 | $481K | Sell |
15,881
-24,741
| -61% | -$800K | ﹤0.01% | 2139 |
|
|
2023
Q1 | $1.32M | Sell |
40,622
-111,959
| -73% | -$3.54M | ﹤0.01% | 1593 |
|
|
2022
Q4 | $4.28M | Sell |
152,581
-4,728
| -3% | -$136K | 0.01% | 932 |
|
|
2022
Q3 | $5.65M | Buy |
157,309
+40,590
| +35% | +$1.43M | 0.01% | 845 |
|
|
2022
Q2 | $3.59M | Buy |
116,719
+46,970
| +67% | +$1.37M | 0.01% | 1063 |
|
|
2022
Q1 | $2.25M | Buy |
69,749
+59,435
| +576% | +$1.56M | ﹤0.01% | 1438 |
|
|
2021
Q4 | $313K | Sell |
10,314
-1,513
| -13% | -$43.4K | ﹤0.01% | 2388 |
|
|
2021
Q3 | $313K | Sell |
11,827
-225
| -2% | -$5.4K | ﹤0.01% | 2297 |
|
|
2021
Q2 | $254K | Sell |
12,052
-766
| -6% | -$15.3K | ﹤0.01% | 2374 |
|
|
2021
Q1 | $259K | Buy |
12,818
+141
| +1% | +$2.68K | ﹤0.01% | 2321 |
|
|
2020
Q4 | $203K | Sell |
12,677
-381
| -3% | -$5.04K | ﹤0.01% | 2356 |
|
|
2020
Q3 | $163K | Sell |
13,058
-34,059
| -72% | -$400K | ﹤0.01% | 2312 |
|
|
2020
Q2 | $335K | Sell |
47,117
-17,388
| -27% | -$116K | ﹤0.01% | 2075 |
|
|
2020
Q1 | $351K | Buy |
+64,505
| New | +$576K | ﹤0.01% | 2015 |
|
|
2019
Q4 | – | Sell |
-665,831
| Closed | -$4.82M | – | 2444 |
|
|
2019
Q3 | $4.82M | Sell |
665,831
-139,955
| -17% | -$1M | 0.01% | 1129 |
|
|
2019
Q2 | $6.41M | Buy |
805,786
+435,574
| +118% | +$5.16M | 0.01% | 1035 |
|
|
2019
Q1 | $4.66M | Buy |
370,212
+215,733
| +140% | +$3.42M | 0.01% | 1168 |
|
|
2018
Q4 | $3.05M | Buy |
154,479
+12,329
| +9% | +$285K | 0.01% | 1307 |
|
|
2018
Q3 | $4.04M | Sell |
142,150
-37,610
| -21% | -$897K | 0.01% | 1270 |
|
|
2018
Q2 | $3.78M | Sell |
179,760
-41,620
| -19% | -$788K | 0.01% | 1333 |
|
|
2018
Q1 | $3.15M | Buy |
221,380
+1,860
| +0.8% | +$26.6K | ﹤0.01% | 1362 |
|
|
2017
Q4 | $2.81M | Sell |
219,520
-55,820
| -20% | -$787K | ﹤0.01% | 1428 |
|
|
2017
Q3 | $4.9M | Buy |
275,340
+146,180
| +113% | +$3.01M | 0.01% | 1156 |
|
|
2017
Q2 | $3.27M | Buy |
+129,160
| New | +$3.11M | ﹤0.01% | 1320 |
|
|
2017
Q1 | – | Sell |
-16,570
| Closed | -$245K | – | 2337 |
|
|
2016
Q4 | $245K | Buy |
+16,570
| New | +$326K | ﹤0.01% | 2201 |
|
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
Prudential Financial's EVH Position: Q1 2026 in Review
Prudential Financial opened a new position in Evolent Health (EVH) in Q1 2026: 18,845 shares worth $43K. The stake represents ﹤0.01% of the portfolio and ranks #2334 among its holdings. This is a return to the name: Prudential Financial previously reported a position in EVH as recently as Q3 2025.
Prudential Financial first reported a position in EVH in Q4 2016 and has held it in 33 quarters since. The position peaked at $6.41M in Q2 2019. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.
- Prudential Financial held 18,845 shares of Evolent Health worth $43K as of Q1 2026.
- Evolent Health was a new Prudential Financial position in Q1 2026.
- Evolent Health made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2334 holding.
- Prudential Financial first reported a position in Evolent Health in Q4 2016 and has held it in 33 quarters since.
- Prudential Financial's Evolent Health position peaked at $6.41M in Q2 2019.
- 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.